Ganglioside Metabolism and Parkinson's Disease
Here we advance the hypothesis that Parkinson's disease (PD) is fundamentally a failure of trophic support for specific classes of neurons, primarily catecholaminergic. Evidence from our laboratory provides a framework into which a broad array of findings from many quarters can be integrated in...
Main Authors: | John Forsayeth, Piotr Hadaczek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnins.2018.00045/full |
Similar Items
-
The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
by: Sandro Sonnino
Published: (2023-09-01) -
The Key Role of GM1 Ganglioside in Parkinson’s Disease
by: Suman Chowdhury, et al.
Published: (2022-01-01) -
GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms
by: Jay S. Schneider
Published: (2023-05-01) -
Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition
by: Maria Fazzari, et al.
Published: (2022-02-01) -
The Future of GDNF in Parkinson's Disease
by: Fredric P. Manfredsson, et al.
Published: (2020-12-01)